A new technology utilizing a blood test is showing promise in the detection of ovarian cancer, according to a study by the Wilmott Cancer Institute at the University of Rochester. Researchers were able to identify “missing” ovarian cancer cells and diagnose tumors in early stages, particularly in individuals with pelvic tissue damage or cysts. The study, led by Richard Moore, director of the Wilmott Cancer Institute’s gynecological oncology program, involved nearly 200 local participants. The findings were published on September 8, 2022, in Obstetrics & Gynecology, Green Journal. A woman experiencing persistent abdominal discomfort that does not resolve within several weeks should consult a general practitioner and undergo a gynecological examination by a gynecologist. Topics: #cancer #new #ovarian Post navigation NEW SCIENTIST ⟩ A large part of carbon sequestration projects has failed BIG GALLERY ⟩ Star Parade: Estonia’s top actors arrive for the premiere of the series